US Stock MarketDetailed Quotes

NGENF NERVGEN PHARMA CORP

Watchlist
  • 1.540
  • -0.010-0.65%
15min DelayClose May 14 16:00 ET
  • 1.546
  • +0.006+0.37%
Post 16:57 ET
107.69MMarket Cap-5539P/E (TTM)

NERVGEN PHARMA CORP Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NERVGEN PHARMA CORP Earnings Date

Currency: CAD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.15

-50.00%
Analyst Rating

Buy

May 14, 2024

NERVGEN PHARMA CORP Earnings Estimates

Revenue

EPS

EBIT

No Data

Analysis

Analyst Rating

Updated: May 14, 2024

Buy

  • Buy

    100.00%

  • Hold

    0.00%

  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg